Results 1 to 10 of about 10,815 (151)

GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment [PDF]

open access: yesBreast Cancer Research, 2017
Background The G protein estrogen receptor GPER/GPR30 mediates estrogen action in breast cancer cells as well as in breast cancer-associated fibroblasts (CAFs), which are key components of microenvironment driving tumor progression.
Ernestina M. De Francesco   +5 more
doaj   +5 more sources

GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential [PDF]

open access: yesJournal of Translational Medicine
G protein-coupled estrogen receptor (GPER) significantly influences metabolic regulation by engaging multiple signaling pathways that affect overall metabolic health. Its structure and signaling mechanisms drive its diverse roles.
Liyan Liu   +21 more
doaj   +2 more sources

Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression

open access: yesHeliyon, 2021
Estrogen is a female sex steroid hormone that plays a significant role in physiological functions. Evidence suggests that estrogen-signaling pathways are closely linked to cancer development and progression. The novel G protein-coupled estrogen receptor (
Zulvikar Syambani Ulhaq   +2 more
exaly   +3 more sources

G-protein-coupled estrogen receptor-1 facilitates chondrocyte proliferation in pubertal epiphyseal growth plate via PTHrP/Ihh regulation [PDF]

open access: yesBone & Joint Research
Aims: Oestrogen drives long-bone development through various oestrogen receptors. G-protein-coupled oestrogen receptor-1 (GPER-1), a membrane oestrogen receptor, mediates longitudinal bone growth during early puberty; however, the underlying mechanisms ...
Ya-Shuan Chou   +6 more
doaj   +2 more sources

Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma [PDF]

open access: yesNeoplasia: An International Journal for Oncology Research
Although aberrant activation of the Hippo/YAP axis has been implicated in the development of gastric cancer, functional studies of this cascade in the context of gastric signet-ring cell carcinoma (GSRC) remain absent. Our previous single-cell sequencing
Yufei Wang   +14 more
doaj   +2 more sources

Reduced Vitellogenesis and Female Fertility in Gper Knockout Zebrafish

open access: yesFrontiers in Endocrinology, 2021
The role G-protein coupled estrogen receptor (GPER) plays in vertebrate reproduction remains controversial. To investigate GPER’s reproductive role, we generated a gper zebrafish mutant line (gper−/−) using TALENs.
Xin-Jun Wu   +5 more
doaj   +1 more source

G protein-coupled estrogen receptor regulates embryonic heart rate in zebrafish. [PDF]

open access: yesPLoS Genetics, 2017
Estrogens act by binding to estrogen receptors alpha and beta (ERα, ERβ), ligand-dependent transcription factors that play crucial roles in sex differentiation, tumor growth and cardiovascular physiology.
Shannon N Romano   +5 more
doaj   +1 more source

Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist

open access: yesPharmacology Research & Perspectives, 2022
Aldosterone exerts some of its effects not by binding to mineralocorticoid receptors, but rather by acting via G protein‐coupled estrogen receptors (GPER).
Qingming Ding   +5 more
doaj   +1 more source

GPER-induced signaling is essential for the survival of breast cancer stem cells. [PDF]

open access: yes, 2020
G protein-coupled estrogen receptor-1 (GPER), a member of the G protein-coupled receptor (GPCR) superfamily, mediates estrogen-induced proliferation of normal and malignant breast epithelial cells.
Chan, Yu-Tzu   +12 more
core   +2 more sources

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients. [PDF]

open access: yesPLoS ONE, 2013
Follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHCGR) were demonstrated to impact upon survival of patients suffering from epithelial ovarian cancer (EOC).
Sabine Heublein   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy